Millennium Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.74M Buy
26,200
+4,800
+22% +$728K ﹤0.01% 3366
2026
Q2
$3.35M Buy
21,400
+5,600
+35% +$840K ﹤0.01% 3362
2026
Q1
$2.41M Buy
15,800
+8,100
+105% +$1.24M ﹤0.01% 3689
2025
Q4
$1.06M Buy
7,700
+1,000
+15% +$131K ﹤0.01% 4441
2025
Q3
$859K Hold
6,700
– – ﹤0.01% 4731
2025
Q2
$811K Sell
6,700
-28,300
-81% -$3.19M ﹤0.01% 4567
2025
Q1
$3.9M Buy
35,000
+18,500
+112% +$1.97M ﹤0.01% 3109
2024
Q4
$1.61M Sell
16,500
-11,900
-42% -$1.27M ﹤0.01% 3809
2024
Q3
$3.27M Sell
28,400
-26,400
-48% -$3M ﹤0.01% 3224
2024
Q2
$5.83M Buy
54,800
+8,100
+17% +$813K ﹤0.01% 2583
2024
Q1
$4.52M Buy
46,700
+37,000
+381% +$3.79M ﹤0.01% 2963
2023
Q4
$979K Sell
9,700
-78,300
-89% -$7.56M ﹤0.01% 4182
2023
Q3
$8.96M Buy
88,000
+23,900
+37% +$2.43M ﹤0.01% 2146
2023
Q2
$6.47M Buy
+64,100
New +$6.41M ﹤0.01% 2419
2019
Q2
– Sell
-223,200
Closed -$19.2M – 4347
2019
Q1
$19.2M Buy
+223,200
New +$17.9M 0.03% 822
2015
Q2
– Sell
-3,236
Closed -$286K – 3673
2015
Q1
$286K Buy
+3,236
New +$287K ﹤0.01% 3069
2014
Q4
– Sell
-6,026
Closed -$508K – 4179
2014
Q3
$508K Buy
6,026
+1,450
+32% +$117K ﹤0.01% 2739
2014
Q2
$371K Buy
+4,576
New +$360K ﹤0.01% 2760

Other funds holding NVS

Millennium Management's NVS Position: Q3 2026 in Review

Millennium Management reduced its Novartis (NVS) stake by 34% in Q3 2026, selling an estimated $38.7M and leaving 503,168 shares worth $71.7M. The position accounts for 0.02% of the portfolio, ranked #684.

Millennium Management first reported a position in NVS in Q2 2013 and has held it in 47 quarters since. The position peaked at $120M in Q3 2018. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Millennium Management held 503,168 shares of Novartis worth $71.7M as of Q3 2026.
  • Millennium Management sold 254,861 Novartis shares in Q3 2026, an estimated $38.7M.
  • Novartis made up 0.02% of Millennium Management's portfolio in Q3 2026, its #684 holding.
  • Millennium Management first reported a position in Novartis in Q2 2013 and has held it in 47 quarters since.
  • Millennium Management's Novartis position peaked at $120M in Q3 2018.
  • 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.